Up-regulation of DNAM-1 and NKp30, associated with improvement of NK cells activation after long-term culture of mononuclear cells from patients with ovarian neoplasia

Hum Immunol. 2014 Aug;75(8):777-84. doi: 10.1016/j.humimm.2014.05.010. Epub 2014 May 29.

Abstract

This study aimed at evaluating the functional activation and activating receptors expression on resting, short- and long-term NK and NK-like T cells from blood of ovarian neoplasia patients. Blood from patients with adnexal benign alterations (n = 10) and ovarian cancer (grade I-IV n = 14) were collected after signed consent. Effector cells activation was evaluated by the expression of the CD107a molecule. Short-term culture was conducted overnight with IL-2 and long-term culture for 21 days, by a method designed to expand CD56(+) lymphocytes. Short-term culture significantly increased NK cells activation compared to resting NK cells (p<0.05), however, the long-term procedure supported an even higher increase (p<0.001). Resting NK-like T cells showed poor activation, which was not altered by the culture procedures. The long-term culture effectively increased the expression of the activating receptors on NK and NK-like T cells, either by increasing the number of cells expressing a given receptor and/or by up-regulating their expression intensity. As a conclusion, the long-term culture system employed, resulted in a high number of functional NK cells. The culture system was particularly efficient on the up-regulation of NKp30 and DNAM-1 receptors on NK cells.

Keywords: CD107a; Degranulation; NCRs (natural cytotoxic receptors); NK-like T lymphocytes; Regulatory T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma, Mucinous / genetics*
  • Adenocarcinoma, Mucinous / immunology
  • Adenocarcinoma, Mucinous / pathology
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Differentiation, T-Lymphocyte / genetics*
  • Antigens, Differentiation, T-Lymphocyte / immunology
  • Case-Control Studies
  • Cystadenocarcinoma, Serous / genetics*
  • Cystadenocarcinoma, Serous / immunology
  • Cystadenocarcinoma, Serous / pathology
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / pathology
  • Lymphocyte Activation
  • Lysosomal-Associated Membrane Protein 1 / genetics
  • Lysosomal-Associated Membrane Protein 1 / immunology
  • Middle Aged
  • Natural Cytotoxicity Triggering Receptor 3 / genetics*
  • Natural Cytotoxicity Triggering Receptor 3 / immunology
  • Neoplasm Staging
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / immunology
  • Ovarian Neoplasms / pathology
  • Ovary / immunology
  • Ovary / pathology
  • Primary Cell Culture
  • Signal Transduction
  • T-Lymphocytes, Regulatory / drug effects
  • T-Lymphocytes, Regulatory / immunology
  • T-Lymphocytes, Regulatory / pathology

Substances

  • Antigens, Differentiation, T-Lymphocyte
  • CD226 antigen
  • Interleukin-2
  • Lysosomal-Associated Membrane Protein 1
  • NCR3 protein, human
  • Natural Cytotoxicity Triggering Receptor 3